Steroid Drug

ApprovedSmall molecule

PPeking Union Medical College Hospital

Steroid Drug is one of 146 small molecule programs targeting Systemic Lupus Erythematosus. It is currently in Approved.

Indications

Total Trials

Active Trials

145

Competitors

Pipeline

Status by Indication[3][1]

Indication

Systemic Lupus ErythematosusActive, not recruiting

Urethral StrictureActive, not recruiting

HemosiderosisActive, not recruiting

Otitis Media With EffusionActive, not recruiting

Rheumatoid ArthritisActive, not recruiting

Myasthenia GravisActive, not recruiting

OsteoarthritisActive, not recruiting

Systemic Lupus ErythematosusApproved

Active, not recruiting

Urethral StricturePreclinical

Active, not recruiting

HemosiderosisPhase 1/Phase 2

Active, not recruiting

Otitis Media With EffusionApproved

Active, not recruiting

Rheumatoid ArthritisPhase 3

Active, not recruiting

Myasthenia GravisPreclinical

Active, not recruiting

OsteoarthritisApproved

Active, not recruiting

Competition

Competitive Landscape

791 competitors in Rheumatoid Arthritis

#DrugCompanyPhaseTrials

Steroid Drug

PPeking Union Medical College Hospital

Approved

1 2

Actemra

Rituxan

61 4

Orencia

Bristol-Myers Squibb

Preclinical

47 5

Simponi

Johnson & Johnson

Preclinical

19 6

Arcoxia

Novartis

Preclinical

4 7

Celexa

AbbVie

Preclinical

1 8

Zelhou

Jiangsu Simcere Pharmaceutical Co., Ltd.

Preclinical

7 9

Kineret

SSwedish Orphan Biovitrum

Preclinical

6 10

Rituxan

Pfizer

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Recruiting

Myasthenia Gravis

NCT06006832

Q4 2026

Phase 1/2Recruiting

Hemosiderosis

NCT05937191

Q3 2027

Post-ApprovalRecruiting

Osteoarthritis

NCT07489521

Clinical

Trials by Indication[1]

Osteoarthritis1 trial

Arthrosemid vs. Steroid for the Management Knee Osteoarthritis

Recruiting·—·Phase 4·NCT07489521·200 enrolled

Myasthenia Gravis1 trial

A Prospective Cohort Study of Myasthenia Gravis in China

Recruiting·PPeking Union Medical College Hospital··NCT06006832·202 enrolled

Hemosiderosis1 trial

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

Recruiting·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Phase 1/2·NCT05937191·34 enrolled

Surgery1 trial

Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)

Completed·—··NCT03390179·250 enrolled

Systemic Lupus Erythematosus1 trial

Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease

Completed·MMallinckrodt·Phase 4·NCT01753401·38 enrolled

6 more indications

Urethral stricture1 trial

Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

Completed·SServices Hospital, Lahore·N/A·NCT05069883·180 enrolled

Women1 trial

To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis

Completed·FFundacion Clinic per a la Recerca Biomédica·Phase 3·NCT04831086·247 enrolled

Rheumatoid Arthritis1 trial

Vitamin D as a Key Player in Rheumatoid Arthritis

Completed·—·Phase 3·NCT04344405·40 enrolled

Anterior Cruciate Ligament Reconstruction1 trial

Ultrasound Guided Adductor Canal Versus Femoral Nerve Blocks for Anterior Cruciate Ligament Reconstruction in Pediatrics

Completed·—·N/A·NCT03053401·52 enrolled

Steroid Injection1 trial

Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With OA of the Hip Compared to Intra-articular Steroid Injections

Unknown status·RRothman Institute Orthopaedics·N/A·NCT03647332·86 enrolled

Otitis Media With Effusion1 trial

Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion

Completed·LLumbini Medical College·Phase 4·NCT03590912·160 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for Steroid Drug. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Steroid Drug compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Steroid Drug. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Peking Union Medical College Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: PPeking Union Medical College Hospital

Steroid Drug

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Q4 2026

Q3 2027

Trials by Indication[1]

Osteoarthritis1 trial

Myasthenia Gravis1 trial

Hemosiderosis1 trial

Surgery1 trial

Systemic Lupus Erythematosus1 trial

Urethral stricture1 trial

Women1 trial

Rheumatoid Arthritis1 trial

Anterior Cruciate Ligament Reconstruction1 trial

Steroid Injection1 trial

Otitis Media With Effusion1 trial

References

Drug Info

Quick Facts

Related News